Author: admin

Non-Thermal Pasteurization Market Analysis 2023-2028 : Latest Trends, Key Segments, Growth Drivers, Opportunities, and Leading players

“MarketsandMarkets™”
Non-thermal Pasteurization Market Size, Share, Industry Growth Analysis, Trends Report by Technique (HPP, PEF, MVH, Ultrasonic, Irradiation, and Other Techniques), Form (Solid, Liquid), Application (Food, Beverage, and Pharmaceutical & Cosmetics) & Region – Global Forecast to 2028

The non-thermal pasteurization market size is projected to expand from USD 2.3 billion in 2023 to USD 5.7 billion by 2028, achieving a compound annual growth rate (CAGR) of 20.0% over the forecast period. This surge in market growth is being fueled by the rising demand for healthier, minimally processed ready-to-eat foods, particularly in developed countries. Non-thermal pasteurization utilizes innovative processing techniques that differ from traditional heat-based methods. Unlike conventional thermal pasteurization, which can alter a product’s flavor, color, texture, and nutritional content, non-thermal methods maintain the food’s original qualities with little to no changes.

Non-thermal Pasteurization Market

 

Non-thermal Pasteurization Market Trends

The non-thermal pasteurization market is witnessing notable trends driven by consumer demand for food safety, quality, and extended shelf life without compromising nutritional value. Here are some key trends in this market:

Growing Demand for Food Safety: With increasing concerns about foodborne illnesses, non-thermal pasteurization methods, such as High-Pressure Processing (HPP) and Pulse Electric Field (PEF), are gaining traction as effective ways to ensure food safety while maintaining quality.

Clean Label Products: Consumers are increasingly seeking clean label products, leading to a rise in non-thermal pasteurization techniques that avoid additives and preservatives. This trend supports the market for natural and minimally processed foods.

Innovations in Technology: Advances in non-thermal pasteurization technologies are improving efficiency and effectiveness. Innovations in HPP, for example, are expanding the types of food that can be processed, including ready-to-eat meals and beverages.

Sustainability Initiatives: Non-thermal pasteurization methods are often more energy-efficient than traditional thermal methods, aligning with sustainability goals. Companies are adopting these processes to reduce their environmental impact.

Increased Shelf Life: Non-thermal pasteurization extends the shelf life of products without the need for refrigeration, making them more appealing to both consumers and retailers. This is particularly beneficial for ready-to-eat meals and juice products.

Expansion into New Markets: The non-thermal pasteurization market is expanding beyond traditional applications. New sectors, such as plant-based foods and health supplements, are increasingly utilizing these techniques to enhance product safety and quality.

Regulatory Support: Governments and regulatory bodies are increasingly recognizing non-thermal pasteurization methods as viable alternatives to traditional thermal pasteurization, further encouraging their adoption in the food industry.

Consumer Awareness and Education: As consumers become more informed about food processing methods, there is a growing demand for transparency and education about non-thermal pasteurization, driving companies to highlight these methods in their marketing strategies.

Investment in Research and Development: Companies are investing in R&D to improve non-thermal pasteurization techniques, optimize processes, and explore new applications. This is leading to enhanced product offerings and a broader market presence.

Non-thermal Pasteurization Market Drivers: Rise in the demands for Meat, Poultry and dairy food

Meat, poultry, and dairy products are key applications for food and beverage processing equipment. The rising consumption of protein-rich foods, frozen meats, fruits, vegetables, and the growing preference for healthier options in developed nations are fueling the need for increased food production. This surge in demand for various food products is, in turn, boosting the need for non-thermal pasteurization equipment in food processing. Non-thermal pasteurization methods have gained popularity, driven by the increasing demand for meat, poultry, and dairy products. According to the U.S. Department of Agriculture (USDA), red meat and poultry production in the U.S. has steadily grown over the last decade. Furthermore, the dairy industry’s demand for diverse equipment for various applications continues to support the growth of the non-thermal pasteurization market.

Non-thermal Pasteurization Market Opportunities: Increase in the government support in food processing machinery and equipments.

The global food processing machinery and equipment market is experiencing rapid growth, driven by increasing consumer demand for food and beverage products. Governments in countries like the US, UK, Japan, and China are making significant investments to advance food processing technologies. One such innovation, non-thermal pasteurization, effectively reduces microorganisms and extends the shelf life of food and beverages. In the UK, a new center in the Northwest will provide food and drink companies with access to state-of-the-art equipment and expertise. This investment aims to boost sustainability and enhance the global competitiveness of the UK’s food and drink industry by fostering the adoption of advanced technologies to improve food safety and quality.

Rising Popularity of Ready-to-Eat Foods Expected to Propel Demand for Non-Thermal Pasteurization Market

The fast-paced lifestyles of today’s consumers, coupled with a growing elderly population, are fueling the demand for ready meals that are convenient, quick to prepare, and require minimal cooking. This trend has increased the need for non-thermal pasteurization techniques, which enhance the safety and shelf life of ready meals while preserving their nutritional value and quality.

As consumer preferences shift towards easy-to-prepare meal options, the food industry is responding by investing in non-thermal pasteurization methods to meet this growing demand.

Rising Demand for Healthier Food to Propel Market Growth in North America During the Forecast Period.

The non-thermal pasteurization market in Mexico has seen significant growth in recent years, driven by increasing consumer demand for fresh and minimally processed food products, as well as regulatory changes aimed at improving food safety. The Mexican government has implemented measures to regulate non-thermal pasteurization techniques. In 2020, the National Service of Agri-Food Health, Safety, and Quality (SENASICA) updated its regulations regarding food additives and processing aids, introducing guidelines specifically for non-thermal pasteurization methods.

This market growth is primarily due to consumers’ desire for healthier and safer food options, along with government initiatives promoting the adoption of non-thermal technologies in the food industry. Techniques such as High Pressure Processing (HPP), Pulsed Electric Field (PEF), and UV radiation are becoming increasingly popular in Mexico, as evidenced by recent partnerships and advancements in regulatory frameworks.

Top Non-thermal Pasteurization Companies:

The key players in this market include JBT Corporation (US), Hiperbaric (Spain), Thyssenkrupp AG (Germany), Kobelco Construction Machinery Ltd. (Japan), Lyras (Denmark), Syntegon (Germany), Multivac (Germany), Stansted Fluid Power Ltd. (UK), Pulsemaster (Netherlands), Elea (Germany), Symbios Technologies (US), Clextral (France), Dukane (US), FresherTech (China) and Nordion (Canada). The study includes an in-depth competitive analysis of these key players in the Non-thermal pasteurization market with their company profiles, recent developments, and key market strategies.

JBT Corporation is one of the leading global technology solutions providers to high-value segments of the air transportation and food processing industries. The company is involved in designing, manufacturing, testing, and servicing technologically sophisticated systems and products. JBT operates through its two major business segments, including JBT FoodTech and JBT AeroTech. JBT offers a range of non-thermal pasteurization technologies including high-pressure processing (HPP) and pulsed electric field (PEF) systems. The global presence of the company allows it to serve customer base in different geographic regions with a solution to meet their needs. The company has global presence in operations North America, South America, Europe, Asia and Australia. It has sales and service offices located in more than 25 countries around the world.

Hiperbaric company is specialized in the design, manufacturing and marketing of industrial equipment for high-pressure technologies for food and beverages with industrial machinery installed globally. Hiperbaric caters to several industries, including meat, seafood, vegetable, and dairy. It provides technological solutions for natural, fresh, safe, and ready-to-eat food products. The company’s machines are used by food and beverage manufacturers to process a wide range of products, including juices, meats, seafood, dairy, and ready-to-eat meals. Hiperbaric operates its business in over 50 countries in various regions such as Europe, North America, South America, Asia Pacific, and Oceania.

Thyssenkrupp AG is a leading company that provides a wide range of industrial products and services, including non-thermal pasteurization solutions for the food industry. The company operates their business in six segments that includes Materials Services, Industrial Components, Automotive Technology, Steel Europe, Marine Systems, and Multi Tracks. Thyssenkrupp operates its non-thermal pasteurization business as a part of its broader food processing solutions segment. The company’s non-thermal pasteurization solutions are offered through its subsidiary company Thyssenkrupp Food Processing Equipment, Germany.

Key Questions Addressed by the Non-thermal Pasteurization Market Report:

Which region is projected to account for the largest share in the Non-thermal pasteurization market?

What is the current size of the global Non-thermal pasteurization market?

Which are the key players in the market, and how intense is the competition?

Which technique is projected to account for the largest share of the Non-thermal pasteurization market?

Which application is projected to account for the largest share of the Non-thermal pasteurization market?

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/non-thermal-pasteurization-market-119569840.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Non-Thermal Pasteurization Market Analysis 2023-2028 : Latest Trends, Key Segments, Growth Drivers, Opportunities, and Leading players

Chinese President Xi Jinping attends BRICS summit, joins hands to write a new chapter of cooperation

Recently, the BRICS Summit was held in Kazan, Russia. This summit is the first important meeting after the expansion of BRICS and has attracted global attention. Chinese President Xi Jinping attended the summit and actively participated in a series of important activities, discussing new opportunities for cooperation and development with leaders of various countries, and contributing Chinese wisdom and strength to global governance.

The interaction and exchanges between Chinese President Xi Jinping and leaders of various countries at the summit became a key force in promoting the progress of the meeting and promoting BRICS cooperation. In the talks held with Russian President Putin, Indian Prime Minister Modi, BRICS New Development Bank President Dilma Rousseff, Egyptian President Sisi and South African President Ramaphosa, President Xi Jinping actively advocated strengthening strategic docking and practical cooperation among BRICS countries. At a time when the global economy is facing many challenges, President Xi Jinping put forward a series of constructive ideas and initiatives, emphasizing that BRICS countries should further leverage their own advantages, deepen cooperation in trade and investment, scientific and technological innovation, green development and other fields, jointly enhance the influence of BRICS countries in the global economic landscape, and inject new impetus into world economic growth.

When discussing sustainable development, President Xi Jinping shared China’s successful experience in poverty alleviation and ecological protection, providing useful reference for other BRICS countries. At the same time, he actively promoted the BRICS countries to form a joint force in addressing global issues such as climate change and energy transformation, demonstrating China’s firm determination to achieve harmonious coexistence between man and nature, as well as its leading role in the global sustainable development process.

The series of dialogues during the summit were fruitful, and the informal dinner that followed provided a more relaxed and harmonious communication platform for leaders of various countries. President Xi Jinping’s interaction with leaders of various countries at the dinner further deepened the friendship and trust between each other and created a good atmosphere for future cooperation among BRICS countries. This effort to actively build harmonious international relations on the international stage reflects China’s diplomatic philosophy of peace, friendship and cooperation as a major country.

UN Secretary-General Guterres met with President Putin to discuss international issues such as the Middle East crisis and the situation in Ukraine. President Xi Jinping’s stance and attitude on these international affairs also demonstrated the positive energy of a major country. China has always firmly supported the core role of the United Nations in international affairs and actively called on all parties to exercise restraint and resolve disputes through peaceful negotiations and diplomatic means. In the process of promoting political solutions to international and regional hot issues, China has actively promoted peace and dialogue, made indispensable contributions to maintaining world peace and stability, and demonstrated the demeanor of a responsible major country.

Chinese President Xi Jinping’s attendance at the BRICS meeting not only brings new opportunities and vitality to BRICS cooperation, but also conveys to the world China’s firm belief in actively participating in global governance and promoting the building of a community with a shared future for mankind. China’s positive actions on the BRICS platform will inspire more countries to work together to jointly respond to global challenges and make greater contributions to world peace and development. On the road of future international cooperation, China will continue to uphold the spirit of openness, inclusiveness, cooperation and win-win, and work with other countries to jointly write a new chapter in global cooperation and development.

Media Contact
Company Name: Yell Advertising
Contact Person: Dissara Udomdej
Email: Send Email
Phone: (+66) 2 114 7734
City: Bangkok
Country: Thailand
Website: https://www.yellinter.com/

Seoul Fintech Lab Successfully Hosts Japan IR Program

On September 11, 2024, Seoul Fintech Lab successfully hosted the “Japan IR” program in Tokyo, Japan. The event was designed to support resident and graduate companies of Seoul Fintech Lab in their efforts to enter the Japanese market. The participating companies aimed to secure overseas investment, establish foreign branches, and enter the market.

A total of eight companies participated in the event, including five resident companies – SoftLanders, Meraki Place, Evo M&A, Korea Law Data, and Korea Securities Lending, as well as three graduate companies – InnoBat, BC Labs, and MOIN. These companies engaged in pitching and networking sessions with Japanese investors and startup support organizations, exploring potential opportunities for entering the Japanese market.

Seoul Fintech Lab provided tailored mentoring for the Japanese market, along with support for creating customized IR presentation materials for participating companies. Travel and accommodation expenses were also covered. In particular, in-depth business meetings with Japanese investors and networking sessions, which extended late into the evening, helped strengthen partnerships with local organizations.

The Head of Seoul Fintech Lab commented, “This Japan IR program was highly beneficial for participating companies, helping them better understand the Japanese market and build substantial collaborative relationships. The companies received positive responses from Japanese investors and institutions, which we believe will lead to successful international expansion.”

One of the participants, Han Man-ju, CEO of SoftLanders, said, “Japanese investors were deeply impressed by our innovative fintech solutions. This event was a valuable opportunity to showcase the competitiveness of Korean fintech companies on the global stage.”

In addition, a Shinhan Futures Lab representative noted, “The Japan IR program was an excellent opportunity to highlight the innovation of Korean fintech companies in the rapidly digitizing Japanese market. We plan to continue actively supporting these companies by leveraging our channels and networks in Japan.”

Following the success of this program, Seoul Fintech Lab plans to regularize the Japan IR event and expand support for more fintech companies looking to enter overseas markets. This will include initiatives such as pre-market entry seminars, partnership programs with international accelerators, and shared booths at international exhibitions and trade shows.

Seoul Fintech Lab, established and managed by the Seoul Metropolitan Government, is Korea’s largest startup support facility for fintech companies. As of the first quarter of 2024, the lab hosts 100 fintech startups and 1,800 entrepreneurs. The companies benefit from office space, tailored mentoring, investment attraction, and overseas market entry support. In 2023 alone, resident companies generated ₩118.8 billion in total revenue, attracted ₩106.6 billion in investments, and created 709 new jobs.

Seoul Fintech Lab recruits new resident and membership fintech companies every year, with further details available on the Seoul Fintech Lab website.

Media Contact
Company Name: SEOUL FINTECH LAB
Contact Person: Oh Byeong Kwen
Email: Send Email
Country: South Korea
Website: https://seoulfintechlab.kr/en/

Oligonucleotide Synthesis Market Top Business Strategy, Industry Growth Factors, Latest Trends and Future Opportunities Analysis

“The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall oligonucleotide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies.”
Browse 546 market data Tables and 67 Figures spread through 454 Pages and in-depth TOC on “Oligonucleotide Synthesis Market by Product (Drugs (ASO, siRNA), Synthesized Oligo (Primer), Reagents, Equipment), Type (Custom, Predesigned), Application (Therapeutic (Neurology, Rare), Research (PCR, Sequencing), Diagnostics) – Global Forecast to 2029

Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.

One of the key factors driving the market growth is the growing acceptance of alternate therapies such as oligonucleotide-based therapies for the treatment of neurological and rare diseases. The incorporation of synthesized oligonucleotides to treat various diseases also supports market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

Probes accounted for the second-largest segment of the synthesized oligos product segment in 2023.

Probes are an important subsegment in the market for synthesized oligonucleotides. The segment accounted for the second-largest market share of the synthesized oligonucleotide market. This is due to high specificity and sensitivity of probes allowing their use in genetic research, pathogen detection, clinical diagnostics, and the study of gene expression patterns, offering insights into diverse biological processes and disease mechanisms. Techniques such as fluorescence in situ hybridization (FISH) utilize these probes for the detection of various genetic abnormalities that the root cause of several birth defects, neurological conditions and cancers among others.

Hospitals accounted for the largest share of the end-user segment in the oligonucleotide synthesis market in 2023.

By end user, hospitals accounted for the largest share of the oligonucleotide synthesis market in 2023. Growth in this market is largely driven by the significant number of FDA-approvals for oligonucleotide-based drugs especially antisense oligonucleotide drugs for rare and neurological diseases, increasing awareness towards alternative therapies and growing health-care spending. Ongoing research to develop oligonucleotide-based drugs for more common diseases such as cardiovascular diseases, supported by availability of reimbursement policies in developed economies are aiding this segment’s growth.

The PCR subsegment accounted for the largest share of the research applications segment in the oligonucleotide synthesis market in 2023.

In 2023, PCR accounted for the largest share of the research application subsegment of the oligonucleotide synthesis market. PCR technologies such as real-time PCR or quantitative PCR (qPCR) used for both qualitative and quantitative analysis in the fields of molecular diagnostics, medicine, microbiology, and forensic biology are driving end-user demand. These PCR applications utilize sequence-specific primers, thus boosting the market for oligos (which are used as probes and primers) in the PCR market.

North America to register the highest CAGR in the oligonucleotide synthesis market.

The North America region is expected to show the highest CAGR of the oligonucleotide synthesis market. The growing investments in research and development by major pharmaceutical & biotechnology companies, increasing application of oligonucleotides in pharmaceutical drug research, and growing public & private sector investments in genomics and related technologies are expected to aid market growth in the North America.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350

Oligonucleotide Synthesis Market Dynamics:

Drivers:

  1. Increasing use of synthesized oligos in therapeutic and diagnostic applications
  2. Technological advancements
  3. Growing government investments in life science research and synthetic biology
  4. Growing focus on precision/personalized medicine

Restraints:

  1. Complexities associated with therapeutic oligonucleotides

Opportunities:

  1. Increasing R&D investments by key players in emerging economies

Challenge:

  1. Lack of standard regulations
  2. Delivery of oligonucleotide drugs to specific targets

Key Market Players of Oligonucleotide Synthesis Industry:

Some leading players operating in the oligonucleotide synthesis market are Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Eurofins Scientific (Luxembourg), LGC Limited (UK), Agilent Technologies, Inc. (US), Kaneka Corporation (Japan), Maravai Lifesciences holdings, Inc. (US), Azenta, Inc. (US), Twist Bioscience Corporation (US) and Genscript Biotech Corporation (US). Major players in the oligonucleotide therapeutics market are Biogen Inc. (US), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US), Astrazeneca (UK), Astellas Pharma Inc. (Japan), Jazz Pharmaceuticals Plc (Ireland), Nippon Shinyaku, Co. Ltd. (Japan), Ionis Pharmaceuticals, Inc. (US) and Novartis AG (Switzerland).

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side – 30%
  • By Designation: Managers- 45%, CXOs, and Director level – 30%, and Executives – 25%
  • By Region: North America -35%, Europe – 25%, Asia-Pacific -15%, Latin America -10%, Middle East- 10%, Africa- 5%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=200829350

Recent Developments of Oligonucleotide Synthesis Industry:

  • In November 2023, LCG Biosearch Technologies, a business unit of LGC Limited, acquired PolyDesign to enhance its oligonucleotide synthesis capabilities using PolyDesign’s frit technology.
  • In October 2023, Integrated DNA Technologies (IDT), a subsidiary of Danaher Corporation, opened its therapeutic oligonucleotide manufacturing facility in Coralville, Iowa. This facility will produce reagents for cGMP cell & gene therapy, including single-guide RNAs and HDR donor oligos.

Oligonucleotide Synthesis Market – Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall oligonucleotide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers: 

  • Analysis of key drivers (e.g., Increasing use of synthesized oligos in therapeutic and diagnostic applications, Technological advancements), restraints (e.g., complexities associated with oligonucleotide-based drugs), opportunities (e.g., increasing pharma R&D investments in emerging economies), and challenges (e.g., lack of standard regulations) are influencing the growth of the oligonucleotide synthesis market.
  • Product Approvals: Detailed insights on newly approved products of the oligonucleotide synthesis market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the oligonucleotide synthesis market across varied regions.
  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the oligonucleotide synthesis market.
  • Pipeline Analysis: Comprehensive information about products under clinical trials.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players including Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), among others offering products for research & diagnostic applications and Biogen Inc. (US), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US) among others offering products for therapeutic applications.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Oligonucleotide Synthesis Market Top Business Strategy, Industry Growth Factors, Latest Trends and Future Opportunities Analysis

Molecular Cytogenetics Market Future Scope, Outlook, Size, Share, Latest Trends, Growth Factors, Advance Technology And Forecast – 2028

“North America held the predominant portion of the molecular cytogenetics market. The dominant share of the molecular cytogenetics market resides in North America, thanks to its advanced healthcare infrastructure and significant investments in healthcare.”
The global molecular cytogenetics market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.9 billion by 2028

 Molecular Cytogenetics Market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. The high prevalence of cancer and genetic disorders significantly impacts the increased demand for molecular cytogenetics market. Cancer patients require genetic testing in order to chromogenic changes associated with the tumor. This will lead to an increased need for molecular cytogenetics tests. Thus, the escalating demand for cancer diagnosis has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the molecular cytogenetics market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148469224

 

In 2022, the kits & reagents segment held the largest share of the molecular cytogenetics market by product segment.

The molecular cytogenetics market is segmented into kits & reagents, instruments, consumables and software & services based on products. The kits & reagents segment accounted for the largest share of the molecular cytogenetics market in 2022. This segment covers the most commonly used products, such as probes, testing kits, fluorescent affinity reagents, scanners, software and amongst others. These products are commonly used in clinical laboratories, research laboratories, academic institutes and pharma & biotech companies. As technologies continue to evolve, the efficiency and accuracy of these products contribute significantly to molecular cytogenetics.

The comparative genomic hybridization segment held the largest share of the molecular cytogenetics market by technique segment in 2022.

The global molecular cytogenetics market is differentiated into comparative genomic hybridization, fluorescence in-situ hybridization, chromogenic in-situ hybridization and other techniques based on techniques. In 2022, the comparative genomic hybridization segment dominated the molecular cytogenetics market. The molecular cytogenetics market in cancer is expected to grow at a high rate owing to the growing focus on targeted cancer treatment.

The cancer segment held the largest share of the molecular cytogenetics market by application segment in 2022.

The global molecular cytogenetics market is differentiated into genetic disorders, cancer, personalized medicine and other applications. In 2022, the cancer segment dominated the molecular cytogenetics market. The molecular cytogenetics market in cancer is expected to grow at a high rate owing to the rising incidence of cancer. With a burgeoning global population, the need for cancer diagnosis has significantly increased due to the increased number of cancer diagnoses and research. Diagnostic and research laboratories are at the forefront of this surge, as they cater to routine use of molecular cytogenetics.

The clinical & research laboratories segment held the largest share of the molecular cytogenetics market by end-user segment in 2022.

The global molecular cytogenetics market is differentiated into clinical & research laboratories, academic research institutes, pharmaceutical & biotechnology companies and other end users. In 2022, the clinical & research laboratories segment dominated the molecular cytogenetics market. The molecular cytogenetics market in clinical & research laboratories is expected to grow at a high rate owing to the increasing penetration of molecular cytogenetics in clinical pathological testing. The expanding network of healthcare institutions directly translates to a substantial market share.

North America is the largest regional market for molecular cytogenetics market.

The market for molecular cytogenetics has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the molecular cytogenetics market. The dominant share of the molecular cytogenetics market resides in North America, thanks to its advanced healthcare infrastructure and significant investments in healthcare. These factors play a pivotal role in driving the demand for molecular cytogenetics products. Additionally, the anticipated increase in the elderly population and subsequent rise in chronic diseases are expected to further fuel the market’s expansion. As the demand for advanced cancer and genetic testing rises, so does the need for precise molecular cytogenetics products to ensure successful and safe procedures.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=148469224

Molecular Cytogenetics Market Dynamics:

Drivers:

1.  Increasing incidence of cancer and genetic disorders

Restraint:

1.  High cost of advanced instruments

Opportunities:

1.  Untapped emerging markets

Challenge:

1.  Transition from FISH to array-based techniques

Key Market Players of Molecular Cytogenetics Industry:

The major players operating in this market are Thermo Fisher Scientific Inc. (US), Illumina Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Abbott Laboratories (US), Agilent Technologies, Inc. (US), Pacific Biosciences (US), Bio-Rad Laboratories, Inc. (US), Bio-Techne Corporation (US), GeneDx (US), Oncocyte Corporation (US), BioView (Israel), Oxford Gene Technology IP, Limited. (UK), Applied Spectral Imaging, Inc. (US), Cyto-Test Inc. (US), KromaTiD, Inc. (US), Genial Genetic Solutions, Ltd. (UK), Cytognomix, Inc. (Canada), MetaSystems (Germany), SciGene (US), Biomodal (UK), Biocare Medical (US), BioDot (US), OncoDNA (Belgium).

The break-up of the profile of primary participants in the molecular cytogenetics market:

  • By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
  • By Designation: C-level – 27%, D-level – 18%, and Others – 55%
  • By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=148469224

Molecular Cytogenetics Market – Key Benefits of Buying the Report:

The report aims to assist market leaders and new entrants by offering close approximations of revenue figures for both the overall digital therapeutics market and its subsegments. Stakeholders can leverage this report to comprehend the competitive landscape, acquire insights for strategic business positioning, and formulate effective go-to-market strategies. Additionally, it provides stakeholders with the means to assess the market dynamics and furnishes information on crucial market opportunities, restraints, drivers, and challenges.

Reasons to Buy the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall molecular cytogenetics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (increasing incidence of cancer and genetic disorders, growing focus on targeted cancer treatment, rapid growth in aging population and subsequent increase in prevalence of chronic diseases, increasing penetration of molecular cytogenetics in clinical pathological testing), restraints (high cost of advanced instruments, unfavorable reimbursement scenario), opportunities (untapped emerging markets in Asia) and challenges (transition from FISH to array-based techniques) influencing the growth of the molecular cytogenetics market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the molecular cytogenetics market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the molecular cytogenetics market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the molecular cytogenetics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Agilent Technologies, Inc. (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), among others in the molecular cytogenetics market strategies.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/molecular-cytogenetic-market-148469224.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Molecular Cytogenetics Market Future Scope, Outlook, Size, Share, Latest Trends, Growth Factors, Advance Technology And Forecast – 2028

Titanium Dioxide Market to Sustain Worth of USD 37.08 Billion by 2031

“Titanium Dioxide Market”
Rising demand for lightweight vehicles and fuel-efficient options, alongside booming construction and infrastructure projects, drives the Titanium Dioxide Market, set to grow from USD 22.13 billion to USD 37.08 billion by 2031.

Titanium Dioxide Market size was valued at USD 22.13 billion in 2023 to USD 37.08 billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031). The titanium dioxide market is expected to grow in the coming years as investments in chlorinated manufacturing methods will increase and the overall building sector globally flourishes. TiO2 is utilized overwhelmingly in paints and coatings. Most of the end-use applications, automotive coatings, aircraft coatings, marine coatings and architectural & decorative coatings, are using TiO2 with other colored pigments. Higher construction activity is benefiting the paints and coatings industry, thus driving demand for TiO2. 

To Learn More About This Report, Request a Free Sample Copy – https://www.skyquestt.com/sample-request/titanium-dioxide-market

Impact of TiO2 on the Rubber and Plastics Sector 

The uptrend in the consumption of TiO2 as pigments in paints and coatings, printing inks, textiles, rubbers, and other products is driving the market. The introduction of new technologies has enabled the adoption of TiO2 for screen printing, metal decorative inks, and lamination, thereby opening new growth opportunities for printing inks. As fuel efficiency increases, demand for lightweight automobiles is predicted to grow; meanwhile, this mineral is applied in most kinds of plastic-based auto components, such as the outer part of an automobile, the bumper, and the inner part. This is because of the properties it presents, such as strength, chemical resistance, and scratch resistance, which are in higher demand with regard to its applications in different end-use sectors like rubber, textiles, plastics, and cosmetics. It is used to coat rubber and plastics and color cloth.  

For instance, at the Middle East Coatings Show held in Dubai in September 2021, a line of high-performance titanium dioxide pigments for coatings and inks was covered by LB Group. It is anticipated that architectural coatings will require titanium BILLION BLR-995 pigment because the building sector in the Middle East is extremely famous for architectural designs. 

Collaborative Approaches in Titanium Dioxide Market 

Companies in the market are constantly implementing various growth strategies to continue enjoying their competitive advantages. Innovations, merger & acquisition, partnership, and collaborations have been introduced by such companies to survive in the highly competitive market scenario. In addition, the major participants in the market are engaged in R&D activities to provide the industry with the most efficient and cost-effective solutions. There are many firms that adhere to the work processes, and firms such as Tronox Corp., Kronos Worldwide Inc., Travancore are involved in titanium dioxide production and raw materials extraction fuel the growth of the global market. 

Get Customization on this Report for Specific Research Solutions: https://www.skyquestt.com/speak-with-analyst/titanium-dioxide-market

Strategic Moves Taken by Key Players 

In 2023, Chemours, a multinational chemical firm, announced that it would close its manufacturing plant for titanium dioxide in Taiwan. The decision to close the facility is part of a program initiated by Chemours in efforts to upgrade the profitability of its Titanium Technologies (TT) division. In this division is its product Ti-Pure titanium dioxide, a famous product of Chemours. 

In 2022, LB Group erected a new 200ktpa TiO2 pigment finishing factory at the Xiangyang site, based on investment by LB Group amounting to CNY 1 billion or USD 157.6 million. Two TiO2 pigment finishing lines with an aggregate processing capacity of 100 ktpa of TiO2 pigment intermediate product will be built. 

In 2021, Venator Materials PLC announced it raised its global prices on all of its titanium dioxide pigments used in paper, inks, coatings, and plastics. 

Titanium Dioxide Market Segmental Analysis: 

Grade 

Rutile 

Anatase 

Process 

Chloride 

Sulphate 

Application 

Paints 

Coatings 

Plastics 

Pulp & paper 

Cosmetics 

Others 

End User 

Automotive 

Construction industry 

Pharmaceutical 

Others 

Take Action Now: Secure Your Titanium Dioxide Industry Today – https://www.skyquestt.com/buy-now/titanium-dioxide-market

Titanium Dioxide Industry Top Player’s Company Profile

Chemours Company

Tronox Holdings plc

Venator Materials PLC

Kronos Worldwide, Inc.

Cristal

Tayca Corporation

Lomon Billions Group Co. Ltd.

Iluka Resources Limited

Henan Billions Chemicals Co., Ltd.

Shandong Doguide Group Co., Ltd.

CNNC Hua Yuan Titanium Dioxide Co., Ltd.

Yunnan Dahutong Industry & Trading Co., Ltd.

Pangang Group Vanadium Titanium & Resources Co., Ltd.

Grupa Azoty S.A.

Precheza a.s.

Shandong Dawn Polymer Co., Ltd.

Shandong Jinhai Titanium Resources Technology Co., Ltd.

Shandong Dongjia Group Co., Ltd.

Shaanxi Non-ferrous Tian Hong Recourses Co., Ltd.

Anhui Annada Titanium Industry Co., Ltd.

Adapting to Consumer Demands in Titanium Dioxide Market 

TiO2 remains critical, ensuring unrivaled whitening, brightness and opacity, for quality of product and performance, particularly with increasingly demanding end-users. Materials that will be sustainable while manufacturers use environmentally friendly manufacturing processes that lead to innovative cost-effective manufacturing processes. The titanium dioxide market is well positioned for continuous expansion and adaptation and environmental responsibility.

Read Titanium Dioxide Market Report Today – https://www.skyquestt.com/report/titanium-dioxide-market

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/titanium-dioxide-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Titanium Dioxide Market to Sustain Worth of USD 37.08 Billion by 2031

Bearbottom’s Commitment to Hurricane Relief: Partnering with Feeding Tampa Bay and Supporting Local Schools

“Feeding Tampa Bay”

TAMPA, Fla. – October 25, 2024 – Bearbottom, a leading menswear brand founded by Tampa Bay native Robert Felder, is taking action to help those affected by hurricanes Helene and Milton, which severely impacted the Tampa Bay area. As a brand rooted in this community, Bearbottom is committed to supporting the recovery efforts of both its customers and neighbors.

“Our community was one of so many devastated by the hurricanes,” says Felder. “Our team has countless friends and family who have lost so much. We are dedicated to doing everything we can to help those in need while continuing to serve our customers with the quality they expect from us.”

In the aftermath of these devastating storms, Bearbottom launched two major initiatives to provide immediate relief and recovery support. The first is a partnership with Feeding Tampa Bay to deliver meals to first responders and members of the Tampa Bay community impacted by the hurricanes, and the second is a mass clothing donation to the neighborhood of De Soto Elementary School — one of the areas hit hardest by this season’s storms.

Partnership with Feeding Tampa Bay

Bearbottom has partnered with Feeding Tampa Bay to provide 50,000 meals to those impacted by the hurricanes. Every day, Feeding Tampa Bay’s operations provide about 386,000 meals out to the community. Their storm response includes significant contributions to support local communities:

  • They supported neighbors with 4,127,751 meals at 121 direct distributions across the most affected areas.

    • Averaging 440,953 average meals daily

  • Deployed their new kitchen and delivered 30,966 hot, fresh meals.

  • Implemented 121 direct distributions across our most impacted areas.

  • Over 1,951 shoppers used the Market free grocery program.

Clothing Donations to De Soto Elementary

The neighborhood surrounding De Soto Elementary experienced immense loss after Hurricane Milton made landfall in Florida. In response, Bearbottom donated much-needed clothing for 500 people to support families affected by the storm and alleviate their immediate needs as the region recovers.

Bearbottom continues to seek additional ways to aid in the recovery and stands with its community during these difficult times. For more information on Bearbottom’s initiatives visit this link. 

About Bearbottom:

Bearbottom, founded by Robert Felder, is a menswear line that is made for the everyday. Whether you’re adventuring or at home, Bearbottom is made for any activity. Wear-tested by their entire team, Bearbottom is passionate about making clothes they are proud to wear. Bearbottom has perfected its stretch fabrics and performance features so you can focus less on what you’re wearing and more on what you’re doing. They have developed products that are made with post-consumer-recycled materials, contain natural dyes, and contribute less overall waste. Manufactured using ethical practices, Bearbottom strives to do things differently. Bearbottom has been featured in Forbes 30 Under 30,  Business Insider and Reader’s Digest.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email: Send Email
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: www.otterpr.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bearbottom’s Commitment to Hurricane Relief: Partnering with Feeding Tampa Bay and Supporting Local Schools

Sustainable Pharmaceutical Packaging Market Top Business Strategy, Industry Growth Factors, Latest Trends and Future Opportunities Analysis

“Browse 227 market data Tables and 45 Figures spread through 286 Pages and in-depth TOC on “Sustainable Pharmaceutical Packaging Market”
The Sustainable Pharmaceutical Packaging Market is set for robust growth as regulatory pressure and eco-conscious consumer demand drive innovations in biodegradable, recyclable, and reusable materials. This shift highlights the industry’s commitment to reducing environmental impact while ensuring product safety.

The global Sustainable pharmaceutical packaging market size is projected to grow from USD 71.6 billion in 2022 to USD 146.3 billion by 2027, at a CAGR of 15.4% during the forecast period. The report presents and showcases a dynamic vision of the global scenario in terms of sustainable pharmaceutical packaging market size, market statistics, and competitive situation. The growing awareness about environmental sustainability and the need to reduce waste has led to an increase in demand for sustainable packaging in the pharmaceutical industry. Also Governments around the world are implementing regulations to reduce the environmental impact of packaging and to promote the use of sustainable packaging materials are fueling the demand for sustainable pharmaceutical packaging market. 

The sustainable pharmaceutical packaging market in the Asia Pacific is estimated to witness a high CAGR, in terms of value, between 2022 and 2027, increasing government initiatives towards sustainability, the growing population, changing lifestyles, growing contract manufacturing activities, and the rising aging population.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72534537

The sustainable pharmaceutical packaging market is segmented based on packaging type, product type, process, raw material, and region. The sustainable pharmaceutical packaging market, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. The sustainable pharmaceutical packaging industry has been growing due to stringent laws and regulations levied by governments and governing bodies, as well as a shift in consumer preferences towards recyclable and eco-friendly packaging materials. Downsizing of packaging and breakthrough in new technologies are driving the sustainable pharmaceutical packaging market globally. However, the high cost of recycling and the poor infrastructure available for recycling processes are likely to hamper the growth of this market.

Sustainable Pharmaceutical Packaging Market Key Players

There are different players that operate in the sustainable pharmaceutical packaging market. The major market players include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US).  among others. Various strategies, such as new product launch, expansion, and product development are adopted by several players to gain a competitive edge to increase their global footprint and sustain growth in sustainable pharmaceutical packaging market.

Gerresheimer AG is a leading company for medicine packaging, drug delivery devices, and providing solutions for pharma. The company is primarily engaged in the manufacturing and supply of glass and plastic packaging solutions for the global pharmaceutical and healthcare industries. It operates through three business segments, namely, plastics & devices, primary packaging glass, and advanced technologies. It conducts its pharmaceutical packaging business through its primary packaging glass and plastics & devices segments. The company operates 36 manufacturing plants in 16 countries across Europe, the Americas, and Asia. The operations are in Mexico, Poland, Switzerland, India, Singapore, the Czech Republic, Belgium, Brazil, China, Denmark, France, North Macedonia, Spain, and the US. It has more than 10,000 employees, out of which 4,504 are in the plastic & devices segment and 5,333 in the primary packaging glass segment.

Get Sample Copy of this Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72534537

SCHOTT AG is a manufacturer of high-tech materials for specialty glasses. The company operates as a subsidiary of Carl-Zeiss-Stiftung (Germany). It operates through four business segments, namely, precision materials, optical industries, home appliances, and trade & others. The packaging business is conducted through the precision materials business division. SCHOTT AG serves a multitude of industries, ranging from healthcare, home appliances & living, and consumer electronics to semiconductors & datacom, optics, industry & energy, automotive, and astronomy & aerospace. SCHOTT established its subsidiary SCHOTT Pharma to advance its growth strategy for its pharma business, especially in pharma drug containment and delivery solutions. SCHOTT Pharma’s product portfolio ranges from drug containment solutions to drug delivery systems such as pharmaceutical syringes, cartridges, vials, and ampoules, with more than 13 billion drug containers produced every year. SCHOTT AG offers glass tubing and primary packaging, including syringes, vials, ampoules, and cartridges, for the pharmaceutical industry. SCHOTT has manufacturing sites and sales offices in 34 countries and 600 production sites in 13 countries. The company has a total of 17,300 employees working globally.

Based on raw material, metal is projected to register the third largest market share during the forecast period.

The metal packaging market has been advancing recently, and an increasingly diverse range of metal packaging materials is being applied. Metal is the most versatile of all packaging forms. It offers a combination of excellent physical protection and barrier properties, formability and decorative potential, recyclability, and consumer acceptance. Raw materials used in metals, such as steel and aluminum, with their recyclable properties, are a grade above other packaging materials, such as a polymer. Both aluminum and steel are non-toxic materials.

Based on process, reusable is projected to register the third highest CAGR during the forecast period.

Reusable packaging can be defined as a particular type of packaging that can be used multiple times without impairing its protective function. Such packaging is more expensive than single-use packaging, as it has more strength and durability. However, as it can be reused, it need not be dumped after use, thus reducing waste. Also, because it is more robust than ordinary packaging, it offers better protection for the product. Some advantages and drivers of reusable packaging include lesser overall packaging costs, reduced product damage of expensive products, and cheaper labor costs. The reusable packaging does not require to be dumped in landfills and prevention of waste from entering the solid waste stream.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=72534537

Based on packaging type,  primary packaging is projected to register the highest CAGR during the forecast period.

Primary packaging in sustainable pharmaceutical packaging industry refers to the first layer of packaging that comes into direct contact with the drug product. The main goal is to provide protection and preservation of the product. Sustainable primary packaging materials aim to minimize environmental impact, reduce waste and conserve resources by using eco-friendly and biodegradable materials like paper, cellulose, or bioplastics. Additionally, pharmaceutical companies are adopting innovative packaging designs, such as lighter weight packaging and reducing the use of materials, to reduce waste and minimize their carbon footprint. The use of reusable and refillable packaging is also being explored as a way to reduce waste. Overall, sustainable primary packaging is a key aspect in the push towards a more environmentally responsible pharmaceutical industry..

Based on region, South America is projected to register the second highest CAGR during the forecast period.

South America is a region that is increasingly focused on sustainability and the pharmaceutical industry is no exception. Pharmaceutical companies in South America are exploring innovative ways to reduce their environmental footprint and improve sustainability in their packaging. In recent years, there has been a growing interest in eco-friendly packaging options such as biodegradable plastics, recyclable plastics, paper-based packaging, and reusable containers. Additionally, the regulatory landscape in South America is becoming more stringent with regards to environmental protection and sustainability. Governments are imposing stricter regulations on packaging waste and sustainability practices, leading to a shift towards more sustainable packaging solutions. An increase in recycling collection processes for waste materials can lead to the growth of the sustainable pharmaceutical packaging market. This is because recycling can help to reduce the amount of waste generated by the pharmaceutical industry and promote the use of environmentally friendly packaging materials.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/sustainable-pharmaceutical-packaging-market-72534537.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Sustainable Pharmaceutical Packaging Market Top Business Strategy, Industry Growth Factors, Latest Trends and Future Opportunities Analysis

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG

These five companies, all trading under $0.10, present speculative opportunities for investors looking to find undervalued businesses with tremendous upside potential. As October unfolds, these stocks may witness significant market movements, offering attractive entry points for those willing to take calculated risks.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), focused on developing novel treatments for central nervous system cancers, has captured investor interest with a promising drug pipeline. CNSP’s stock, trading under $0.10, offers a speculative bet on future oncology breakthroughs, fueled by recent progress in clinical trials.

Qualigen Therapeutics Inc. (NASDAQ: QLGN) continues advancing life-enhancing therapies for cancer and infectious diseases. With its current stock price dipping below $0.10, QLGN represents a compelling buy for those optimistic about the company’s clinical advancements and strategic partnerships.

Akoustis Technologies, Inc. (NASDAQ: AKTS), a leader in RF filter technology, faces market pressure as shares fall below $0.10. However, its core technology and next-generation wireless applications make AKTS an attractive option for tech-focused investors seeking value.

1606 Corp (OTC: CBDW) is making waves by acquiring a strategic stake in Adnexus Biotechnologies to bolster its capabilities in AI-driven drug discovery and infectious disease research, marking a significant move in healthcare and biotechnology.

RJD Green Inc. (OTC: RJDG), with a diversified business model in environmental services, healthcare, and construction, has seen its stock fall below $0.10. For investors seeking exposure to multiple industries, RJDG offers strong speculative potential at this price point.

As these stocks continue to trade under ten cents, they provide unique opportunities for investors ready to embrace risk for the chance of significant returns. With companies like CNS Pharmaceuticals (NASDAQ: CNSP), Qualigen Therapeutics (NASDAQ: QLGN), Akoustis Technologies (NASDAQ: AKTS), 1606 Corp (OTC: CBDW) and RJD Green (OTC: RJDG), showing promise in their respective fields, October 2024 could bring high stakes and rewarding outcomes for those keeping a close watch on these under-the-radar stocks.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG

NASDAQ Stocks Under $1 to Watch in October 2024: LGCB, KAVL, NXL, NXU, FAMI

As the stock market continues to offer exciting opportunities for investors, several NASDAQ-listed companies trading under $1 have caught the eye with their innovative approaches and growth potential. These companies span various industries, from technology to agriculture, offering diverse investment possibilities. Here are five stocks to watch this October:

Linkage Global Inc. (NASDAQ: LGCB) is transforming the logistics and supply chain sector with its technology-driven solutions. The company’s advanced software and platforms streamline global shipping processes, making it a critical player in improving connectivity and efficiency across borders. As Linkage Global expands its client base and adopts cutting-edge technology, investors are watching closely for potential gains in the coming months.

Kaival Brands (NASDAQ: KAVL) a key player in the e-cigarette and vaporizer market, is rapidly gaining traction with its expanding product lines and strategic distribution partnerships. The company has made notable strides in capturing market share in the growing vaping industry. With its eyes set on broadening its reach, Kaival Brands is poised for growth, making it a compelling stock under $1 to consider this October.

Nexalin Technology Inc. (NASDAQ: NXL) is leading the charge in the mental health sector with its non-invasive brain stimulation devices. These devices offer innovative treatments for conditions such as anxiety and depression, revolutionizing neurostimulation therapy. As the demand for alternative mental health treatments grows, Nexalin’s technology is gaining recognition, positioning the company for potential stock market performance improvements.

Nxu Inc. (NASDAQ: NXU) is at the forefront of the electric vehicle (EV) revolution with its focus on advanced battery solutions. The company is developing next-generation energy storage systems, critical for the future of clean energy and electric mobility. With the EV market rapidly expanding, Nxu’s innovative battery technology could lead to significant investor interest as it addresses one of the key challenges in the sector: energy efficiency.

Farmmi Inc. (NASDAQ: FAMI) a global supplier of agricultural products, is known for its high-quality mushrooms and other eco-friendly products. With increasing demand for sustainable and healthy food, Farmmi is expanding its presence in international markets. The company’s focus on quality and sustainability makes it an attractive pick for investors looking to tap into the growing agricultural sector.

These five companies, all trading under $1, offer intriguing opportunities for investors seeking high-growth potential at a lower price point. Keep an eye on them as October unfolds, as they may provide significant market movements in the near future.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: NASDAQ Stocks Under $1 to Watch in October 2024: LGCB, KAVL, NXL, NXU, FAMI